Cited by 224Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanismsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Quantifying the early stages of remyelination following cuprizone-induced demyelination

Open access
Stidworthy, Mark F., Genoud, Stephane, Suter, Ueli, Mantei, Ned, Franklin, Robin J. M.·2003·Brain Pathology

Abstract

The demyelinating toxin cuprizone is used increasingly in mouse studies of central nervous system remyelination. The value of this model for such studies depends on an accurate description of its quantifiable features. We therefore investigated histology and ultrastructure during the early oligodendrocyte differentiation phase of remyelination in mice given cuprizone and allowed to recover for 2 weeks. Limiting the dose of cuprizone to 0.2% overcame significant mouse morbidity and weight loss seen with a 0.4% dose, but the distribution of cuprizone-induced demyelination was anatomically variable. The caudal corpus callosum and dorsal hippocampal commissure mostly demyelinated at this dose, but the rostral corpus callosum and rostral cerebellar peduncles did not. This variable response, together with small axon diameters and hence thin myelin sheaths, hindered analysis of the progress of early remyelination. The proportion of myelinated and unmyelinated axons in defined regions followed expected trends, but there was pronounced variation between animals. Furthermore, group mean G ratios did not change as expected during the early stages of remyelination, and regression analysis revealed a complex relationship between axon diameter and myelin sheath thickness during this period. We also noted axonal pathology that persisted for at least 2 weeks after cuprizone withdrawal.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1750-3639.2003.tb00032.x

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Myelin formed during repair of experimental demyelination or during demyelinating injury or disease is thinner on average (larger g-ratio) than myelin formed during normal development, although this is less pronounced for smaller-diameter axons such as those in the optic nerve.

    “It is well documented that myelin formed during repair of experimental demyelination or during demyelinating injury or disease is thinner on average (larger g-ratio) than myelin that is formed during normal development (e.g., Lasiene et al., 2008), although this is less pronounced for smaller-diameter axons such as those in the optic nerve (Stidworthy et al., 2003).”

    From Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling (2013) · cites this paper as Stidworthy et al., 2003

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Stidworthy, M. F., Genoud, S., Suter, U., Mantei, N., & Franklin, R. J. M.
Affiliations
  • University of Cambridge (GB)
  • ETH Zurich (CH)
Corresponding author
Franklin, Robin J. M.
Venue
Brain Pathology
Publisher
Wiley
Published
2003-07
Volume
13
Issue
3
Pages
329-339
ISSN
  • 1015-6305 (ISSN-L)
  • 1750-3639
OpenAlex
W2147554232
Cited by
224
References
28
Citations by year
2026: 5 · 2025: 6 · 2024: 11 · 2023: 6 · 2022: 10 · 2021: 8 · 2020: 9 · 2019: 15 · 2018: 17 · 2017: 22 · 2016: 8 · 2015: 13 · 2014: 10 · 2013: 18 · 2012: 8
FWCI
1.53
Type
journal article
Language
en
Open access
Locations
  • Brain Pathology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
cuprizone, remyelination, demyelination, oligodendrocyte differentiation, corpus callosum, hippocampal commissure, cerebellar peduncles, axon diameter, myelin thickness, g-ratio, axonal pathology, dose-dependent toxicity, mouse model
MeSH terms
Animals, Axons, Chelating Agents, Corpus Callosum, Cuprizone, Demyelinating Diseases, Disease Models, Animal, Hippocampus, Mice, Inbred C57BL, Microscopy, Electron, Myelin Sheath, Regression Analysis, Sex Characteristics, Time Factors, Prosencephalon, Mice, Knockout, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review